Minoryx and Neuraxpharm team to provide new therapy for rare CNS disorders
10 Nov 2022 //
EUROPEANPHARMACEUTICALREVIEW
Minoryx‘s marketing authorization application for lead candidate leriglitazone
20 Sep 2022 //
PHARMIWEB
Minoryx presents topline results from Ph2/3 “ADVANCE” study significant
26 Jan 2021 //
PHARMIWEB
EIB provides Minoryx with up to €25 million to support development
30 Oct 2020 //
EIB
Minoryx & Sperogenix to develop and commercialize leriglitazone
22 Sep 2020 //
PRNASIA